Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Hydralazine Hydrochloride Patent Expiration

Hydralazine Hydrochloride was first introduced by Novartis Pharmaceuticals Corp in its drug Apresoline on Approved Prior to Jan 1, 1982. 44 different companies have introduced drugs containing Hydralazine Hydrochloride.


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydralazine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Hydralazine Hydrochloride. The first generic version for Hydralazine Hydrochloride was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Baxter Healthcare Corp and was approved on Jul 17, 2025.

Given below is the list of companies who have filed for Hydralazine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.